Getagraph.com logo
NASDAQ Composite: ( -0.01%) 16 735
S&P 500
(0.80%) 5 277.51 points
Dow Jones
(1.51%) 38 686 points
Nasdaq
(-0.01%) 16 735 points
Oil
(-0.94%) $77.18
Gas
(0.35%) $2.58
Gold
(-0.79%) $2 347.70
Silver
(-3.10%) $30.56
Platinum
(0.63%) $1 044.50
USD/EUR
(-0.17%) $0.921
USD/NOK
(-0.49%) $10.49
USD/GBP
(-0.05%) $0.785
USD/RUB
(0.15%) $90.40

Realtime updates for Evaxion Biotech A/S [EVAX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated31 May 2024 @ 16:00
25% discount on Stockinvest.us - Use code: Podcast

2.23% $ 3.67

BUY 156440 min ago

@ $4.00

Issued: 13 Feb 2024 @ 15:29

Return: -8.25%

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):

Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections...

Stats
Today's Volume 10 056.00
Average Volume 32 638.00
Market Cap 19.14M
EPS $0 ( 2024-05-29 )
Next earnings date ( $-0.490 ) 2024-08-16
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.680
ATR14 $0.0400 (1.09%)

Evaxion Biotech A/S Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Evaxion Biotech A/S Financials

Annual 2023
Revenue: $73 112.00
Gross Profit: $73 112.00 (100.00 %)
EPS: $-8.11
FY 2023
Revenue: $73 112.00
Gross Profit: $73 112.00 (100.00 %)
EPS: $-8.11
FY 2022
Revenue: $0
Gross Profit: $-571 319 (0.00 %)
EPS: $-9.80
FY 2021
Revenue: $0.00
Gross Profit: $0.00 (0.00 %)
EPS: $-1.514

Financial Reports:

No articles found.

Evaxion Biotech A/S Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Evaxion Biotech A/S

Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. The company was incorporated in 2008 and is headquartered in Hørsholm, Denmark.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 1.0235719680786 seconds
Number of API calls: 2
Number of DB calls: 8